# Agios Pharmaceuticals, Inc.: insider transactions

AGIO · Nasdaq · CIK 1439222 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/agio.md) · [Financials](/companies/agio/financials.md) · [Filings](/companies/agio/filings.md) · [Insiders](/companies/agio/insiders.md)

## All transactions: 4

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Gheuens Sarah](/insiders/1881190.md) | Chief Medical Officer, Officer | Sale (S) | 500 | $37.52 | $18.8k | [Form 4](/filings/0001439222-26-000122.md) |
| 2026-10-22 | [Gheuens Sarah](/insiders/1881190.md) | Chief Medical Officer, Officer | Option exercise (M) | 500 | $25.01 | $12.5k | [Form 4](/filings/0001439222-26-000122.md) |
| 2026-10-21 | [Gheuens Sarah](/insiders/1881190.md) | Chief Medical Officer, Officer | Sale (S) | 1,489 | $37.53 | $55.9k | [Form 4](/filings/0001439222-26-000122.md) |
| 2026-10-21 | [Gheuens Sarah](/insiders/1881190.md) | Chief Medical Officer, Officer | Option exercise (M) | 1,489 | $25.01 | $37.2k | [Form 4](/filings/0001439222-26-000122.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 16:12 ET. No prices; not investment advice.